Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer’s Disease: A Double-Blind, Randomized, Placebo-Controlled Trial - Concepedia

Concepedia

Publication | Open Access

Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer’s Disease: A Double-Blind, Randomized, Placebo-Controlled Trial

DOI Full Paper Access

111

Citations

28

References

2017

Year

Prasad R. Padala, Kalpana P. Padala, Shelly Lensing, Daniel Ramirez, Varun Monga, Melinda M. Bopp, Paula K. Roberson, Richard A. Dennis, Frederick Petty, Dennis H. Sullivan,

American Journal of Psychiatry

Abstract

Methylphenidate improved apathy in a group of community-dwelling veterans with mild Alzheimer's disease. Methylphenidate also improved cognition, functional status, caregiver burden, CGI scores, and depression.

References

	Year	Citations

Page 1